Schuh_1976_Naunyn.Schmiedebergs.Arch.Pharmacol_293_11

Reference

Title : Interaction of hexafluorenium with human plasma cholinesterase in comparison with hexamethonium - Schuh_1976_Naunyn.Schmiedebergs.Arch.Pharmacol_293_11
Author(s) : Schuh FR
Ref : Naunyn Schmiedebergs Arch Pharmacol , 293 :11 , 1976
Abstract :

1. The influence of the 2 alkane-bis-onium compounds hexafluorenium (HF1) and hexamethonium (C6) on human plasma cholinesterase (ChE) was studied with respect to the type of inhibition. 2. HF1 and C6 are reversible inhibitors of ChE. The inhibitory potency of HF1 (pI50 = 6.96; Ki = 2.4 x 10(-9)) is about 40 000-fold higher than that of C6 (pI50 = 2.4; Ki = 6.7 x 10(-2)). 3. The kinetic analysis displayed a competitive (C6) and a non-competitive (hf1) mechanism of action. 4. The inhibition of ChE by C6 is induced by a binding of C6 to the anionic site of the active center thus impairing the primary formation of the enzyme-substrate complex. HF1, however, is most probably bound to anionic side receptors in the vicinity of the active center; by that a conformational change of the enzyme protein is induced impairing the acylation step of the esteratic site.

PubMedSearch : Schuh_1976_Naunyn.Schmiedebergs.Arch.Pharmacol_293_11
PubMedID: 948350

Related information

Inhibitor Mylaxen

Citations formats

Schuh FR (1976)
Interaction of hexafluorenium with human plasma cholinesterase in comparison with hexamethonium
Naunyn Schmiedebergs Arch Pharmacol 293 :11

Schuh FR (1976)
Naunyn Schmiedebergs Arch Pharmacol 293 :11